Superior Group of Companies, Inc. (SGC)
—Data provided by IEX. Delayed 15 minutes.
$160.3M
$251.5M
13.6
5.57%
+4.1%
+1.8%
+36.8%
-25.8%
Explore Other Stocks In...
Valuation Measures
Financial Highlights
Balance Sheet Strength
Similar Companies
Company Profile
At a glance
• Thesis: SGC's century-honed diversification and proactive tariff management create a resilient business model positioned for margin recovery as macro headwinds abate. The company's three-segment structure, redundant sourcing network, and $13 million cost reduction program provide a foundation for earnings power that isn't reflected in current depressed valuations.
• Critical Gap Between Pipeline and Performance: Management reports record pipelines across all segments, yet Q3 2025 revenue declined 7.5% year-over-year with compressed margins. The investment case hinges on whether SGC can convert this pipeline into actual revenue and margin expansion—success would drive significant operating leverage, while failure suggests structural demand issues.
• Margin Inflection in Motion: Gross margins fell across all three segments in Q3 (Branded Products to 34.8%, Healthcare to 38.5%, Contact Centers to 52.9%), but price increases implemented in July/August 2025 and the full impact of cost reductions should drive sequential improvement. The company has demonstrated ability to pass through tariff costs, suggesting pricing power remains intact despite customer hesitancy. Loading interactive chart...
• Valuation Reflects Maximum Pessimism: Trading at 0.45x EV/Revenue and 10.3x EV/EBITDA with a strong current ratio of 2.94x, SGC's enterprise value implies minimal growth expectations. However, the 155% payout ratio raises questions about dividend sustainability and capital allocation priorities at a time when investment in growth initiatives may be more valuable.
• Key Risk/Reward Driver: Tariff volatility and trade agreement uncertainty (AGOA and HOPE/HELP expired September 2025) could pressure margins further, but SGC's early supply chain diversification and Haiti manufacturing provide competitive advantages over less-prepared rivals. The solar customer bankruptcy ($2 million annualized impact) and Jamaica contact center closure demonstrate segment-specific risks that diversification helps mitigate.
Price Chart
Loading chart...
Growth Outlook
Profitability
Competitive Moat
How does Superior Group of Companies, Inc. stack up against similar companies?
Financial Health
Valuation
Peer Valuation Comparison
Returns to Shareholders
Financial Charts
Financial Performance
Profitability Margins
Earnings Performance
Cash Flow Generation
Return Metrics
Balance Sheet Health
Shareholder Returns
Valuation Metrics
Financial data will be displayed here
Valuation Ratios
Profitability Ratios
Liquidity Ratios
Leverage Ratios
Cash Flow Ratios
Capital Allocation
Advanced Valuation
Efficiency Ratios
Superior Group of Companies: Tariff-Tested Diversification Meets Margin Inflection (NASDAQ:SGC)
Superior Group of Companies (SGC) operates three diversified segments: Branded Products serving retail and tech industries with customized merchandise; Healthcare Apparel offering scrubs and protective wear primarily to healthcare laundries and consumers; and Contact Centers providing nearshore BPO services. SGC leverages century-long operational adaptability, supply chain diversification including Haiti manufacturing, and AI-driven efficiencies to navigate macroeconomic volatility and sustain margins amid tariffs and industry headwinds.
Executive Summary / Key Takeaways
-
Thesis: SGC's century-honed diversification and proactive tariff management create a resilient business model positioned for margin recovery as macro headwinds abate. The company's three-segment structure, redundant sourcing network, and $13 million cost reduction program provide a foundation for earnings power that isn't reflected in current depressed valuations.
-
Critical Gap Between Pipeline and Performance: Management reports record pipelines across all segments, yet Q3 2025 revenue declined 7.5% year-over-year with compressed margins. The investment case hinges on whether SGC can convert this pipeline into actual revenue and margin expansion—success would drive significant operating leverage, while failure suggests structural demand issues.
-
Margin Inflection in Motion: Gross margins fell across all three segments in Q3 (Branded Products to 34.8%, Healthcare to 38.5%, Contact Centers to 52.9%), but price increases implemented in July/August 2025 and the full impact of cost reductions should drive sequential improvement. The company has demonstrated ability to pass through tariff costs, suggesting pricing power remains intact despite customer hesitancy.
-
Valuation Reflects Maximum Pessimism: Trading at 0.45x EV/Revenue and 10.3x EV/EBITDA with a strong current ratio of 2.94x, SGC's enterprise value implies minimal growth expectations. However, the 155% payout ratio raises questions about dividend sustainability and capital allocation priorities at a time when investment in growth initiatives may be more valuable.
-
Key Risk/Reward Driver: Tariff volatility and trade agreement uncertainty (AGOA and HOPE/HELP expired September 2025) could pressure margins further, but SGC's early supply chain diversification and Haiti manufacturing provide competitive advantages over less-prepared rivals. The solar customer bankruptcy ($2 million annualized impact) and Jamaica contact center closure demonstrate segment-specific risks that diversification helps mitigate.
Setting the Scene: A Century of Adaptation
Superior Group of Companies, organized in 1920 and incorporated in 1922, has spent over a century evolving from a surgical manufacturing company into a strategically diversified provider of branded merchandise, healthcare apparel, and contact center services. This evolution reflects a core competency that defines the investment case: the ability to adapt to macroeconomic shocks while maintaining operational continuity. The company's 1998 redomicile to Florida and 2018 name change to Superior Group of Companies coincided with a deliberate expansion beyond commoditized uniform manufacturing into higher-margin, fragmented markets where agility and customization create competitive moats.
SGC operates through three distinct segments that serve as natural hedges against each other's cyclicality. The Branded Products segment (BAMKO and HPI) produces customized merchandising solutions and promotional products for retail, food service, entertainment, and technology industries. The Healthcare Apparel segment (Wink, Fashion Seal Healthcare, CID Resources, and licensed Carhartt Medical) manufactures and sells scrubs, lab coats, and protective apparel to healthcare laundries, distributors, and direct-to-consumer channels. The Contact Centers segment (The Office Gurus) provides nearshore business process outsourcing and call center support to North American customers.
This diversification matters because it transforms SGC from a single-industry player into a multi-channel platform that can shift resources and capabilities across end markets. When healthcare apparel faces institutional budget freezes, branded products can capitalize on technology sector growth. When contact centers experience client downsizing, the apparel segments can leverage redundant manufacturing capacity. This structural flexibility, combined with a redundant sourcing network spanning multiple countries including company-owned facilities in Haiti, has historically provided a crucial buffer against macroeconomic uncertainties—most recently evidenced during the COVID-19 pandemic when BAMKO pivoted to produce PPE, and during the current tariff environment where early supply chain diversification is now paying dividends.
The company makes money through a hybrid model: direct sales of manufactured and sourced products (apparel and branded merchandise) and service-based revenue from contact center operations. Gross margins vary significantly by segment—52.9% in Contact Centers, 38.5% in Healthcare Apparel, and 34.8% in Branded Products in Q3 2025—reflecting different value propositions. The contact center business, while smallest by revenue, generates the highest margins due to nearshore labor arbitrage and technology-enabled efficiency. The apparel segments compete on design, quality, and speed-to-market, with healthcare apparel benefiting from brand loyalty and branded products leveraging customization capabilities.
SGC's place in the value chain is as a specialized intermediary that combines manufacturing expertise with sourcing agility. Unlike rental-focused competitors such as Cintas or UniFirst , SGC sells products outright, providing customers with asset ownership and customization flexibility. This positioning creates a different customer base—more focused on marketing departments and procurement managers rather than facilities managers—while exposing the company to different cyclical pressures tied to marketing budgets and capital spending rather than employment levels alone.
Technology and Strategic Differentiation: AI as Efficiency Engine
While SGC isn't a technology company in the traditional sense, its strategic differentiation increasingly depends on technology-enabled efficiency and customer experience improvements. The Contact Centers segment exemplifies this evolution through its deployment of AI across talent acquisition, agent training, and real-time customer interaction guidance. The "Guru Assist" system provides next-best-action guidance to agents during calls, improving accuracy, reducing average handle time, and increasing customer satisfaction. This matters because it directly addresses the primary cost driver in contact centers—labor—while improving service quality. In an environment where agent costs are rising and gross margins compressed to 52.9% in Q3, AI-driven efficiency gains could be the difference between margin erosion and expansion.
The Branded Products segment is implementing software automation to make sales representatives more efficient, particularly in product selection and mockup generation. Management notes that product selection is the most time-consuming aspect of the branded merchandise business, requiring staff to manually search multiple websites and create proposals. By deploying AI agents to automate this process—analyzing historical order data, current trends, and customer parameters—the company can serve more customers with fewer resources while improving proposal quality. This initiative, combined with recruiting additional sales representatives, aims to capture market share in a highly fragmented industry where SGC already ranks among the top 10 providers out of over 25,000 competitors.
In Healthcare Apparel, the strategic focus is on digital channel expansion and demand creation for Wink and Carhartt Medical brands. The company is investing in both wholesale digital platforms and direct-to-consumer capabilities, recognizing that healthcare workers increasingly research and purchase apparel online. This omnichannel approach matters because it allows SGC to capture margin upside (direct-to-consumer carries higher gross margins) while building brand equity that transcends traditional distributor relationships. The Haiti manufacturing facilities provide a duty advantage that competitors sourcing exclusively from Asia cannot match, particularly important as trade agreements like AGOA and HOPE/HELP expired in September 2025.
These technology investments are not R&D expenses in the traditional sense but rather operational improvements with measurable ROI. The $13 million in annualized cost reductions includes efficiency gains from these initiatives, suggesting management views technology as a margin driver rather than a cost center. The strategic implication is that SGC is building scalable capabilities that will compound as revenue grows—if the company can convert its record pipelines into actual sales, the operating leverage could be substantial.
Financial Performance: Margin Pressure Meets Cost Action
SGC's Q3 2025 results paint a picture of a company under macroeconomic pressure but actively managing controllable factors. Consolidated net sales fell 7.5% to $138.5 million, with all three segments declining. Gross margin compressed 210 basis points to 38.3%, driven by customer mix in Branded Products, an unfavorable comparison to prior-year product costs in Healthcare Apparel, and higher agent costs in Contact Centers. Net income decreased accordingly, reflecting both lower sales and reduced operational leverage.
The segment-level performance reveals distinct challenges and underlying strengths. Branded Products revenue declined 8.1% to $85.1 million, but this included an $8 million impact from sales pull-forward into Q2 and was partially offset by $2.9 million from the December 2024 3Point acquisition. Management emphasizes that pipeline and order backlog remain very strong. Gross margin fell 140 basis points to 34.8% due to customer sales mix, but the segment's ability to pass through tariff costs and its top-10 market position suggest pricing power remains intact. The 3Point acquisition added new blue-chip customers and experienced talent, contributing to revenue growth and demonstrating management's disciplined M&A approach.
Healthcare Apparel revenue declined 4.6% to $31.5 million, with gross margin falling 330 basis points to 38.5%. The decline reflects macro uncertainty impacting both institutional healthcare apparel and wholesale consumer channels. However, the segment benefits from secular growth drivers in healthcare employment and the company's ability to leverage Haiti sourcing for duty advantages. Price increases initiated in July and August 2025 largely offset tariff impacts in Q3, showing management's proactive stance. The segment's single-digit market share in a fragmented industry represents a long-term growth opportunity if SGC can successfully invest in digital channels and drive demand for its Wink and Carhartt brands.
Contact Centers revenue declined 9.5% to $22.7 million, with gross margin falling 200 basis points to 52.9%. The closure of the Jamaica contact center on June 15, 2025, created an unfavorable margin mix, while macroeconomic headwinds led to client downsizing and attrition outpacing new customer acquisitions. The bankruptcy of a large solar industry customer in Q2 2025 cost approximately $2 million in annualized revenue. Despite these headwinds, the segment remains SGC's highest-margin business, and management reports a strong pipeline with new customer conversions beginning to materialize. AI implementation across talent acquisition, sales enablement, and real-time agent guidance positions the segment for improved efficiency and customer satisfaction.
The balance sheet provides both strength and strategic questions. As of September 30, 2025, SGC had access to a $125 million revolving credit facility and a $75 million term loan, with the ability to request an additional $75 million in incremental facilities. The weighted average interest rate on outstanding borrowings was 5.40%, down from prior-year levels, reducing interest expense to $1.4 million in Q3. The company was in compliance with its fixed charge coverage ratio (minimum 1.25x) and net leverage ratio (maximum 4.0x), indicating adequate covenant headroom.
Cash flow from operations was just $1.3 million for the nine months ended September 30, 2025, with $10.5 million of cash outflows for inventory purchases. The inventory build reflects both sales decreases in Healthcare Apparel and strategic timing of purchases to support expected back-half demand and avoid stockouts. While this working capital investment pressured near-term cash flow, it positions the company to fulfill orders as pipelines convert.
Capital allocation presents a tension. The company paid $6.7 million in dividends during the first nine months of 2025 and had approximately $12.3 million remaining under its $17.5 million share repurchase program as of September 30. Management considers share repurchases a "favorable use of cash" and has been actively buying back stock at prices around $10.26 per share. However, the 155% payout ratio raises questions about dividend sustainability, particularly when the company is simultaneously investing in growth initiatives and maintaining acquisition capacity.
Outlook: Pipeline Conversion and Margin Recovery
Management's guidance evolution tells a story of cautious optimism amid uncertainty. After initially projecting 2025 revenue of $585-595 million (up to 5% growth), the company revised its outlook to $550-575 million following April's tariff announcements, citing heightened economic uncertainty and customer decision-making delays. By Q3, management tightened the range to $560-570 million, raising the midpoint while acknowledging continued macro headwinds.
This guidance trajectory matters because it suggests management has visibility into a back-end weighted recovery. The company expects Q4 to build month-over-month, particularly in Branded Products, as pipeline conversions accelerate and price increases take full effect. Management explicitly states that pipelines remain "strong" and "the largest we've ever seen" across all three segments, with new business opportunities at various stages of diligence and negotiation.
The critical question is timing. Management notes that while pipelines are robust, decision-making cycles have elongated due to tariff uncertainty and macro volatility. However, they also observe "green shoots" as companies face pressure to improve efficiency and margins, making SGC's value proposition more compelling. The solar customer bankruptcy and Jamaica closure represent one-time impacts that should not recur, providing a cleaner baseline for 2026 performance.
Acquisition strategy remains active but disciplined. Management is evaluating opportunities in Branded Products and Contact Centers, seeking businesses that are "immediately accretive" with strong leadership and culture. The 3Point acquisition appears to be integrating well, contributing $9.1 million to year-to-date revenue and bringing new blue-chip customers. The company maintains that it has capacity for M&A while simultaneously repurchasing shares, suggesting confidence in its financial position.
The tariff environment remains fluid but potentially stabilizing. Management noted that recent tariff announcements were "positive" and could "normalize things a bit," potentially accelerating order placement as uncertainty clears. SGC's ability to pass through tariff costs—either through contract provisions or PO-by-PO pricing—provides a degree of protection, though timing lags can create temporary margin pressure. The Haiti manufacturing advantage becomes more valuable if Asian sourcing faces higher duties, potentially driving market share gains from competitors who lack diversified supply chains.
Risks and Asymmetries: What Could Break the Thesis
The most material risk is a failure to convert record pipelines into actual revenue. If customer hesitancy persists or worsens due to recessionary pressures, SGC's cost structure may not be able to adjust quickly enough to protect profitability. The 155% payout ratio becomes particularly concerning in this scenario, as maintaining the dividend could constrain investment in growth or force debt usage, while cutting the dividend could signal deeper problems and damage investor confidence.
Trade policy uncertainty represents a structural risk beyond management's control. The expiration of AGOA and HOPE/HELP agreements on September 30, 2025, could increase costs for products sourced from Africa and Haiti if these agreements are not renewed. While SGC's diversified sourcing mitigates this risk, a complete loss of preferential trade status would pressure gross margins or require costly supply chain reconfiguration. The company's heavy reliance on China for fabrics and hard goods in the Branded Products segment creates additional exposure to escalating tariffs and geopolitical tensions.
Customer concentration and segment-specific vulnerabilities could amplify downside. The solar customer bankruptcy demonstrated how quickly a large client can disappear, and while SGC's diversification limits single-customer risk, the Contact Centers segment's exposure to macro-sensitive industries (solar, retail, food service) makes it vulnerable to sector-specific downturns. The Healthcare Apparel segment's dependence on institutional customers creates risk around healthcare budget cycles and employment trends.
Technology disruption in the Contact Centers segment represents a longer-term threat. AI-driven automation could reduce demand for human agents in routine tasks, potentially shrinking the addressable market by 20-30% over time. While SGC is deploying AI to enhance agent productivity rather than replace agents, the segment's high margins may attract pure-play AI competitors who can offer comparable service at lower cost.
On the positive side, significant asymmetry exists if macro conditions improve. The combination of $13 million in annualized cost reductions, price increases already implemented, and record pipelines creates potential for substantial operating leverage. If tariff uncertainty clears and customer decision-making normalizes, revenue growth could accelerate faster than expenses, driving margin expansion beyond historical levels. The fragmented nature of SGC's markets means even modest share gains could translate into meaningful revenue growth, while the company's scale and sourcing advantages could enable margin expansion through better terms with suppliers and customers.
Valuation Context: Pricing in Minimal Expectations
At $10.18 per share, Superior Group of Companies trades at an enterprise value of approximately $256 million, representing 0.45x trailing twelve-month revenue of $565.7 million and 10.3x EBITDA. These multiples suggest the market is pricing in minimal growth expectations and persistent margin pressure.
Relative to direct competitors, SGC's valuation appears depressed. Cintas (CTAS) trades at 7.4x EV/Revenue and 28.2x EV/EBITDA, reflecting its dominant market position and recurring rental model. UniFirst (UNF) trades at 1.3x EV/Revenue and 9.5x EV/EBITDA, while Aramark (ARMK) trades at 0.8x EV/Revenue and 11.2x EV/EBITDA. SGC's multiple is closest to Aramark's, despite having a more focused and potentially higher-margin business mix.
The company's balance sheet strength supports valuation. With a current ratio of 2.94x and debt-to-equity of 0.58x, SGC has adequate liquidity to navigate near-term headwinds. The weighted average interest rate of 5.40% on outstanding borrowings is manageable, and the company maintains compliance with all debt covenants. Net cash provided by operating activities was modest at $1.3 million for the nine-month period, but this was impacted by strategic inventory builds and working capital investments that should reverse as sales accelerate.
The dividend yield of 5.49% appears attractive at first glance but must be evaluated in context of the 155% payout ratio. Management has expressed commitment to maintaining the dividend "as financial conditions permit," but the math suggests either earnings must recover quickly or the dividend will be unsustainable. The active share repurchase program—$4 million in Q2 at an average price of $10.26—indicates management believes the stock is undervalued, but continued buybacks at this pace could strain cash flow if profitability doesn't improve.
Valuation metrics that matter most for SGC's stage are EV/Revenue and EV/EBITDA, as they capture the company's ability to generate cash from its diversified operations while accounting for its capital structure. The low revenue multiple suggests skepticism about growth, while the moderate EBITDA multiple indicates expectations of continued but compressed profitability. For a company with SGC's scale, market positions, and cost reduction initiatives, these multiples could expand significantly if management demonstrates even modest revenue growth and margin recovery.
Conclusion: A Show-Me Story with Asymmetric Upside
Superior Group of Companies represents a classic "show me" investment opportunity. The market has priced the stock for minimal growth and persistent margin pressure, yet management has implemented concrete actions—$13 million in cost reductions, strategic price increases, AI-driven efficiency gains, and disciplined capital allocation—that position the company for significant operating leverage if macro conditions stabilize.
The central thesis hinges on two variables: pipeline conversion and margin recovery. Record pipelines across all three segments provide revenue visibility that isn't reflected in current valuations, but only actual conversion will validate management's optimism. The cost reduction program and price increases create a clear path to margin expansion, but execution must overcome continued tariff uncertainty and customer hesitancy.
SGC's century-long history of adaptation, diversified business model, and proactive supply chain management provide competitive advantages that become more valuable in volatile environments. While near-term headwinds are real, the company's valuation, liquidity position, and strategic actions create an asymmetric risk/reward profile. For investors willing to look through current margin pressure, SGC offers exposure to a diversified industrial platform trading at recession-level multiples with multiple catalysts for recovery in 2026.
If you're interested in this stock, you can get curated updates by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.
Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.
Loading latest news...
No recent news catalysts found for SGC.
Market activity may be driven by other factors.